Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemia Type II

Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.

39 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipoproteinemia Type II trial results

Completed

A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)

NCT00730236

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Robarts Research Institute London, Ontario, Canada
  • Lipid Clinic and University of Montreal Community Genomic Medicine Center Chicoutimi, Quebec, Canada
View Trial Details
Completed

A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

NCT02434497

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Research Site Brussels (Woluwé-St-Lambert), Belgium
  • Research Site Chicoutimi, Quebec, Canada
  • Research Site Copenhagen, Denmark
  • Research Site Halfa, Israel
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

NCT02226198

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Research Site Brussels (Woluwé-St-Lambert), Belgium
  • Research Site Chicoutimi, Quebec, Canada
  • Research Site København Ø, Denmark
  • Research Site Haifa, Israel
View Trial Details
Completed

Study to Evaluate the Effects of MBX-8025 in Patients With HoFH

NCT02472535

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Ecogene-21 Chicoutimi, Quebec, Canada
  • Montreal Heart Institute Montreal, Quebec, Canada
  • Endocrinologie metabolisme et prevention cardiovasulaire, Institut E3M et IHU cardiometabolique (ICAN), Hôpital Pitié Salpêtrière Paris, France
  • Radbound UMC Nijmegen, Netherlands
View Trial Details
Active, Not Recruiting

Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia

NCT06832371

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +18 more
Locations
  • CHRU Lille - Centre Hospitalier Universitaire de Lille Lille, France
  • Centre Hospitalier Universitaire de Lyon (CHU Lyon) Lyon, France
  • Hôpital de la Conception - Assistance Publique Hôpitaux de Marseille (AP-HM) Marseille, France
  • Hôpital La Pitié Salpêtrière - Groupe Hospitalier "La Pitié Salpêtrière - Charles Foix" Paris, France
View all 30 locations
View Trial Details

Related conditions